Data for (Study ST000673)

(Analysis AN001032)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2
CerP 34:1; [M-H]-@5.97 0.7529 1.1074
CL 70:5; [M-2H](2-)@5.92 0.6699 1.1435
CL 72:3; [M-2H](2-)@7.51 0.8771 1.0534
CL 74:1; [M-2H](2-)@7.51 0.7872 1.0925
CL 74:7; [M-2H](2-)@6.12 0.7536 1.1071
CL 78:1; [M-2H](2-)@7.97 1.0754 0.9672
CL 78:9; [M-2H](2-)@6.71 0.7414 1.1124
FFA(16:0) 0.9397 1.0262
FFA(18:0) 0.9569 1.0187
FFA(18:1) 0.8533 1.0638
FFA(18:2) 0.7624 1.1033
FFA(20:0) 0.9485 1.0224
FFA(20:1) 0.7769 1.0970
FFA(20:2) 0.9233 1.0334
FFA(20:4) Arachidonic acid 0.8232 1.0768
FFA(22:0) 0.9130 1.0378
FFA(22:1) 0.7982 1.0877
FFA(22:2) 0.7475 1.1098
FFA(22:3) 0.9309 1.0301
FFA(24:0) 0.8514 1.0646
FFA(24:1) 0.7859 1.0931
FFA(24:2) 0.7848 1.0935
FFA(24:3) 0.8757 1.0540
lysoPE 16:0; [M-H]-@1.70 0.9130 1.0378
lysoPE 18:0; [M-H]-@2.47 0.7297 1.1175
lysoPE 18:1; [M-H]-@1.83 0.8827 1.0510
lysoPE 18:2; [M-H]-@1.37 0.7203 1.1216
lysoPE 20:3; [M-H]-@1.61 1.0733 0.9681
lysoPE 20:4; [M-H]-@1.33 0.9276 1.0315
lysoPE 22:4; [M-H]-@1.87 0.7238 1.1201
lysoPE 22:6; [M-H]-@1.27 0.7237 1.1201
PA 33:2; [M-H]-@1.84 0.7405 1.1128
PC 28:0; [M-Ac-H]-@5.44 0.8709 1.0561
PC 30:0; [M-Ac-H]-@6.17 1.0026 0.9989
PC 30:1; [M-Ac-H]-@5.60 1.1205 0.9476
PC 31:0; [M-Ac-H]-@6.38 0.8743 1.0546
PC 32:0; [M-Ac-H]-@6.83 1.0345 0.9850
PC 32:1; [M-Ac-H]-@6.29 1.1665 0.9276
PC 32:2; [M-Ac-H]-@5.79 0.7494 1.1090
PC 33:0; [M-Ac-H]-@7.06 1.1313 0.9429
PC 33:1; [M-Ac-H]-@6.63 0.8747 1.0545
PC 33:2; [M-Ac-H]-@6.17 0.8157 1.0801
PC 34:3; [M-Ac-H]-@5.99 0.7947 1.0892
PC 35:1; [M-Ac-H]-@7.30 1.0497 0.9784
PC 35:2; [M-Ac-H]-@6.80 0.8743 1.0547
PC 35:4; [M-Ac-H]-@6.10 0.8661 1.0582
PC 36:2; [M-Ac-H]-@7.05 0.8295 1.0741
PC 37:4; [M-Ac-H]-@6.73 0.9970 1.0013
PC 37:5; [M-Ac-H]-@6.21 0.8188 1.0788
PC 38:2; [M-Ac-H]-@7.76 0.9330 1.0291
PC 38:5; [M-Ac-H]-@6.54 0.9104 1.0390
PC 38:7; [M-Ac-H]-@5.68 0.6937 1.1332
PC 39:6; [M-Ac-H]-@6.60 0.7479 1.1096
PC 40:7; [M-Ac-H]-@6.38 0.7091 1.1265
PC 40:8; [M-Ac-H]-@5.93 0.8537 1.0636
PC 42:1; [M-Ac-H]-@9.50 0.7196 1.1219
PE 32:1; [M-H]-@6.26 1.0489 0.9787
PE 34:0; [M-H]-@6.86 0.8608 1.0605
PE 34:1; [M-H]-@6.87 0.6958 1.1323
PE 34:2; [M-H]-@6.41 0.7860 1.0931
PE 34:3; [M-H]-@6.02 0.7034 1.1290
PE 34:4; [M-H]-@5.76 0.5782 1.1834
PE 35:0; [M-H]-@7.66 0.7429 1.1118
PE 35:1; [M-H]-@7.22 0.9039 1.0418
PE 35:2; [M-H]-@6.77 0.8721 1.0556
PE 36:0; [M-H]-@7.94 0.9348 1.0283
PE 36:1; [M-H]-@7.48 0.7901 1.0912
PE 36:2; [M-H]-@6.47 0.7642 1.1025
PE 36:5; [M-H]-@6.02 0.6420 1.1557
PE 37:4; [M-H]-@6.72 0.8425 1.0685
PE 38:1; [M-H]-@7.94 1.0448 0.9805
PE 38:2; [M-H]-@7.53 0.9617 1.0166
PE 38:3; [M-H]-@7.28 1.0038 0.9984
PE 38:5; [M-H]-@6.53 0.7581 1.1052
PE 38:7; [M-H]-@6.04 0.6822 1.1382
PE 39:6; [M-H]-@6.59 0.8582 1.0616
PE 40:4; [M-H]-@7.48 0.8870 1.0491
PE 40:5; [M-H]-@7.26 0.9640 1.0156
PE 40:8; [M-H]-@6.00 0.5105 1.2128
PE 42:1; [M-H]-@9.00 0.8776 1.0532
PG 32:0; [M-H]-@5.73 1.1734 0.9246
PG 32:1; [M-H]-@5.23 1.3355 0.8541
PG 33:0; [M-H]-@6.03 1.1267 0.9449
PG 34:1; [M-H]-@5.80 1.0424 0.9816
PG 34:2; [M-H]-@5.31 0.8870 1.0491
PG 36:0; [M-H]-@6.87 1.1312 0.9429
PG 36:1; [M-H]-@6.13 1.3069 0.8666
PG 36:2; [M-H]-@6.07 0.8835 1.0506
PG 36:3; [M-H]-@5.28 0.7393 1.1134
PG 36:4; [M-H]-@4.85 0.7440 1.1113
PG 36:4; [M-H]-@5.39 0.9337 1.0288
PG 38:4; [M-H]-@6.03 0.8797 1.0523
PG 40:5; [M-H]-@6.04 1.3107 0.8649
PG 40:6; [M-H]-@5.58 1.1373 0.9403
PG 40:7; [M-H]-@5.10 0.9070 1.0404
PG 40:8; [M-H]-@4.56 0.7345 1.1154
PI 34:1; [M-H]-@5.66 0.6852 1.1369
PI 34:2; [M-H]-@5.21 0.5882 1.1790
PI 36:2; [M-H]-@5.85 0.5748 1.1849
PI 36:3; [M-H]-@5.36 0.7688 1.1005
PI 36:4; [M-H]-@5.20 0.7602 1.1043
PI 38:3; [M-H]-@6.05 0.8846 1.0502
PI 38:4; [M-H]-@5.84 0.7763 1.0972
PI 38:5; [M-H]-@5.32 0.8881 1.0486
PI 38:6; [M-H]-@5.05 0.7398 1.1131
PI 40:5; [M-H]-@5.97 0.8211 1.0778
PI 40:6; [M-H]-@5.76 0.5399 1.2001
PI 40:8; [M-H]-@4.77 0.9986 1.0006
plasmenyl-PE 32:0; [M-H]-@7.12 1.0968 0.9579
plasmenyl-PE 34:0; [M-H]-@7.28 0.9058 1.0409
plasmenyl-PE 34:3; [M-H]-@6.40 0.7842 1.0938
plasmenyl-PE 36:3; [M-H]-@6.93 0.8361 1.0712
plasmenyl-PE 36:5; [M-H]-@6.36 0.6077 1.1706
plasmenyl-PE 38:1; [M-H]-@8.31 0.7914 1.0907
plasmenyl-PE 38:2; [M-H]-@7.94 0.6478 1.1531
plasmenyl-PE 38:5; [M-H]-@6.78 0.7898 1.0914
plasmenyl-PE 40:1; [M-H]-@8.74 0.8125 1.0815
plasmenyl-PE 40:2; [M-H]-@8.34 0.6808 1.1388
plasmenyl-PE 40:3; [M-H]-@8.05 0.7671 1.1013
plasmenyl-PE 40:4; [M-H]-@7.81 0.6649 1.1457
plasmenyl-PE 40:5; [M-H]-@7.53 0.8356 1.0715
plasmenyl-PE 42:4; [M-H]-@8.28 0.8924 1.0468
plasmenyl-PE 42:5; [M-H]-@7.94 0.8153 1.0803
plasmenyl-PE 42:6; [M-H]-@7.81 0.6510 1.1518
PS 34:1; [M-H]-@5.79 0.8262 1.0756
PS 36:1; [M-H]-@6.67 0.8576 1.0619
PS 36:2; [M-H]-@5.92 0.8135 1.0811
PS 36:4; [M-H]-@5.31 1.0182 0.9921
PS 38:3; [M-H]-@6.19 1.0580 0.9748
PS 38:4; [M-H]-@5.94 0.7685 1.1007
PS 38:5; [M-H]-@5.47 0.8877 1.0488
PS 38:6; [M-H]-@5.19 0.8487 1.0658
PS 40:6; [M-H]-@5.85 0.7271 1.1186
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Diagnosis:Control
F2Diagnosis:SIDS
  logo